asa glp 1 guidelines Perioperative management of patients taking glucagon-like peptide-1 receptor agonists: a restrictive fasting regimen is not necessary. Comment on Br J Anaesth 2025; 135: 48–78 The 2023 ASA position on

Artunc-Ulkumen B, Pala HG, Pala EE, et al

Additionally, it is noted that greater research is required to determine the outcomes in patients who have had previous treatment with antidiabetic medications, or whether there are different effects within the class of GLP-1RAs antidiabetic medications

It does not make your medication stronger or weaker

The US Food and Drug Administrations (FDA) independent advisory panel has recommended modifying the labeling of these two drugs to improve their cardiovascular safety profile

56 reported an effect of hepatic FGF21 in inducing WAT lipolysis, suggesting that the early lipolytic effect of G49 can be boosted by liver-derived FGF21 whose increase in plasma was detected from 12 h post-injection peaking at 72 h